Christos Sotiriou (@c_sotiriou) 's Twitter Profile
Christos Sotiriou

@c_sotiriou

Head of the Breast Cancer Translational Research Laboratory, Université Libre de Bruxelles (ULB), Medical Oncologist, Jules Bordet Institute, Brussels, Belgium

ID: 361090896

linkhttp://www.bordet.be calendar_today24-08-2011 07:08:28

266 Tweet

882 Followers

300 Following

Christine Desmedt (@christinedesme2) 's Twitter Profile Photo

Read why we believe rapid autopsy programmes = a global effort to advance research on metastatic cancer 🤝. They are associated with many challenges, but offer so many opportunities. Lisa Carey, MD, ScM, FASCO Nature Reviews Cancer OncoAlert nature.com/articles/s4156…

Daniel Stover, MD, FASCO (@stoverlab) 's Twitter Profile Photo

"Scientists need more time to think" ➡️This perspective speaks to me! 💯 -Administrative bloat, email overuse, meetings for meetings...pull time away. Finding time to think is very hard...but essential. 🤔 nature.com/articles/d4158…

Christos Sotiriou (@c_sotiriou) 's Twitter Profile Photo

Finally, our paper on TNBC spatial characterisation is out in Nat Commun, It was a longue journey. Special thanks to Xiao, David and Joakim Lundeberg pubmed.ncbi.nlm.nih.gov/39592577/

Stephanie Graff, MD, FACP, FASCO (@drsgraff) 's Twitter Profile Photo

If you aren’t in “Special Session 3: Sex, Drugs, Rock & Roll” you missed Dr. Don Dizon make sex puns and give advice on best positions and if that’s not the best of SABCS, I don’t know what is. #SABCS24 👏🏻 #sexualhealth #patientcenteredcare

If you aren’t in “Special Session 3: Sex, Drugs, Rock &amp; Roll” you missed Dr. Don Dizon make sex puns and give advice on best positions and if that’s not the best of <a href="/SABCSSanAntonio/">SABCS</a>, I don’t know what is. #SABCS24 👏🏻 #sexualhealth #patientcenteredcare
Guilherme Nader Marta (@guinadermarta) 's Twitter Profile Photo

Great discussion by Christos Sotiriou at #SABCS24 Lobular BC Spotlight Session dissecting data on immune infiltration in ILC & its impact on outcomes, featuring interesting spatial transcriptomics-based classification in ILC presented by Matteo Serra OncoAlert

Great discussion by <a href="/c_sotiriou/">Christos Sotiriou</a> at #SABCS24 Lobular BC Spotlight Session dissecting data on immune infiltration in ILC &amp; its impact on outcomes, featuring interesting spatial transcriptomics-based classification in ILC presented by <a href="/Matteo_Serra/">Matteo Serra</a> 

<a href="/OncoAlert/">OncoAlert</a>
Georges-L BOUCHEZ (@glbouchez) 's Twitter Profile Photo

😳 « Fermer une chaîne de télévision est une atteinte grave à la liberté d'expression. (…) A cette allure-la, on va pouvoir interdire tout ce qui déplaît. » ⚖️ « Qu'une autorité administrative, ou le conseil d'administration d'une chaîne de télévision, détermine sur la base,

😳 « Fermer une chaîne de télévision est une atteinte grave à la liberté d'expression. (…) A cette allure-la, on va pouvoir interdire tout ce qui déplaît. »
⚖️ « Qu'une autorité administrative, ou le conseil d'administration d'une chaîne de télévision, détermine sur la base,
soria (@jsoriamd) 's Twitter Profile Photo

CHIP is a common, age-related condition where mutated blood stem cells expand without causing blood disorders. CHIP raises the risk of hematological malignancies, chronic inflammatory diseases (like heart & lung disease), & lung cancer. This manuscript shows that CHIP somatic

CHIP is a common, age-related condition where mutated blood stem cells expand without causing blood disorders. CHIP raises the risk of hematological malignancies, chronic inflammatory diseases (like heart &amp; lung disease), &amp; lung cancer. This manuscript shows that CHIP somatic
Paolo Tarantino (@ptarantinomd) 's Twitter Profile Photo

3rd positive Press release in <3 weeks: DB11 achieved positive results, with neoadjuvant T-DXd->THP improving pCR rates over AC-THP in high-risk HER2+ BC. Many open questions. But, overall, great optimism. And a reinforced certainty: 2025 will be #ADCYear. astrazeneca.com/media-centre/p…

3rd positive Press release in &lt;3 weeks: DB11 achieved positive results, with neoadjuvant T-DXd-&gt;THP improving pCR rates over AC-THP in high-risk HER2+ BC. Many open questions. But, overall, great optimism. And a reinforced certainty: 2025 will be #ADCYear. astrazeneca.com/media-centre/p…
Over (@overeventi) 's Twitter Profile Photo

NEXT Oncology – The past, the present, the future of ADC in oncology I farmaci #ADC rappresentano una delle tecnologie più promettenti nella terapia oncologica. In questa sessione di NEXT Oncology ne esploriamo l’evoluzione, dal loro sviluppo iniziale fino alle applicazioni

NEXT Oncology – The past, the present, the future of ADC in oncology
I farmaci #ADC rappresentano una delle tecnologie più promettenti nella terapia oncologica. In questa sessione di NEXT Oncology ne esploriamo l’evoluzione, dal loro sviluppo iniziale fino alle applicazioni